Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy

NCT01490450 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
165
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CSL Behring